Guanhao Biotech Co.,Ltd. (SHE:300238)

Guanhao Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	121.85	106.78	105.14	126.28	159.31	156.2
Cash & Short-Term Investments	121.85	106.78	105.14	126.28	159.31	156.2
Cash Growth	25.98%	1.56%	-16.74%	-20.73%	1.99%	11.91%
Accounts Receivable	57.95	59.55	61.14	71.98	106.71	116.35
Other Receivables	2.3	2.21	13.36	8.74	11.04	14.36
Receivables	60.25	61.75	74.51	80.72	117.75	130.71
Inventory	73.84	78.46	71.6	61.68	140.55	126.9
Other Current Assets	26.49	18.8	16.03	30.22	17.81	24.22
Total Current Assets	282.43	265.79	267.28	298.89	435.41	438.03
Property, Plant & Equipment	328.26	332.47	252.04	214.6	245.54	220.63
Long-Term Investments	18.05	22.49	32.08	32.56	74.22	87.55
Goodwill	-	-	-	-	214.33	214.33
Other Intangible Assets	77.83	72.7	78.66	87.49	64.14	73.99
Long-Term Deferred Tax Assets	18.34	18.42	14.97	13.16	41.44	54.79
Long-Term Deferred Charges	30.58	29.88	24.17	23.58	23.66	29.82
Other Long-Term Assets	8.75	12.65	9.41	-	-	15.58
Total Assets	764.24	754.4	678.59	670.27	1,099	1,135
Accounts Payable	13.27	35.65	29.32	2.16	1.88	3.01
Accrued Expenses	9.45	59.45	58.01	52.96	83	76.53
Short-Term Debt	20.01	20.01	24.52	49.05	51.56	102.88
Current Portion of Long-Term Debt	-	0.09	-	-	54.69	50.17
Current Portion of Leases	5.86	5.64	6.07	7.49	9.51	-
Current Income Taxes Payable	12.16	4.71	3.96	13.72	14.62	2.61
Current Unearned Revenue	27.37	28.76	21.97	28.29	17.1	27.21
Other Current Liabilities	57.83	23.69	28.86	35.32	29.91	40.3
Total Current Liabilities	145.96	177.99	172.72	188.99	262.27	302.7
Long-Term Debt	99	76	12.02	-	-	54.6
Long-Term Leases	5.17	6.62	12.06	22.52	35.62	-
Long-Term Unearned Revenue	19.12	19.43	20.65	22.85	40.94	49.45
Long-Term Deferred Tax Liabilities	6.68	6.77	4.9	4.97	11.74	11.32
Total Liabilities	275.93	286.81	222.33	239.33	350.58	418.07
Common Stock	265.16	265.16	265.16	265.16	265.16	265.16
Additional Paid-In Capital	594.54	594.54	600.27	600.27	597.71	599.02
Retained Earnings	-256.08	-270.95	-298.37	-329.37	-21.57	-96.01
Comprehensive Income & Other	-46.41	-46.39	-46.46	-50.71	-57.38	-37.9
Total Common Equity	557.21	542.36	520.59	485.34	783.92	730.27
Minority Interest	-68.89	-74.77	-64.33	-54.4	-35.76	-13.61
Shareholders' Equity	488.31	467.59	456.26	430.94	748.16	716.66
Total Liabilities & Equity	764.24	754.4	678.59	670.27	1,099	1,135
Total Debt	130.04	108.35	54.67	79.06	151.38	207.64
Net Cash (Debt)	-8.19	-1.57	50.47	47.22	7.93	-51.44
Net Cash Growth	-	-	6.88%	495.52%	-	-
Net Cash Per Share	-0.03	-0.01	0.20	0.18	0.03	-0.20
Filing Date Shares Outstanding	265.16	265.16	265.16	265.16	265.16	265.16
Total Common Shares Outstanding	265.16	265.16	265.16	265.16	265.16	265.16
Working Capital	136.48	87.8	94.56	109.9	173.14	135.33
Book Value Per Share	2.10	2.05	1.96	1.83	2.96	2.75
Tangible Book Value	479.38	469.66	441.93	397.85	505.45	441.95
Tangible Book Value Per Share	1.81	1.77	1.67	1.50	1.91	1.67
Buildings	-	392.83	225.53	239.59	239.59	245.94
Machinery	-	99.41	99.17	101.29	106.02	106.6
Construction In Progress	-	2.54	73.99	2.8	2.41	2.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.